Skip to content

Evaluation of an Ayurvedic Combination Therapy (Vyoshadi Guggulu and Kathakakhadiradi Pana) on Insulin Resistance in Women with Polycystic Ovary Syndrome

Combined effect of Vyoshadi Guggulu tablet with Kathakakhadiradi Pana on insulin resistance in Polycystic Ovarian Syndrome (PCOS)- a single arm clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102438
Enrollment
20
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

RAKHI RAVINDRAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 20 to 35 years diagnosed with PCOS based on Rotterdam criteria 2018, with BMI between 25 and 34.9 and HOMA IR above 1

Exclusion criteria

Exclusion criteria: Uncontrolled systemic illness Diagnosed cases of Cushing s syndrome, Androgen secreting tumors, Hyperprolactinemia Known case of malignancy Known case of diabetes Pregnant or lactating mothers

Design outcomes

Primary

MeasureTime frame
Changes in HOMA-IRTimepoint: 0th day, 91st day and 121st day

Secondary

MeasureTime frame
Changes in BMI Changes in Waist hip ratio Changes in intervals of consecutive menstrual bleeding Changes in lipid profileTimepoint: 0th day, 91st day and 121st day

Countries

India

Contacts

Public ContactDr Maya Balakrishnan

Government Ayurveda Medical College

rakhi.ravindran88@gmail.com9778033340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026